About
Technology
Issues
FAQ
Links
Official Page
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.